These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2427475)

  • 1. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.
    CMAJ; 1994 Jul; 151(2):159-66. PubMed ID: 7518734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated maternal serum alpha-fetoprotein values. How low is high?
    Lenke RR; Guerrieri J; Nemes JM; Kurczynski TW; French B; Gray M; Schut H; Ashwood ER
    J Reprod Med; 1989 Aug; 34(8):511-6. PubMed ID: 2478705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening.
    Norem CT; Schoen EJ; Walton DL; Krieger RC; O'Keefe J; To TT; Ray GT
    Obstet Gynecol; 2005 Oct; 106(4):747-52. PubMed ID: 16199631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects.
    Papp Z; Tóth Z; Török O; Szabó M
    Am J Med Genet; 1987 Jan; 26(1):103-10. PubMed ID: 2433941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients.
    Richards DS; Seeds JW; Katz VL; Lingley LH; Albright SG; Cefalo RC
    Obstet Gynecol; 1988 Feb; 71(2):203-7. PubMed ID: 2447540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
    Nadler HL; Simpson JL
    Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
    Doran TA; Valentine GH; Wong PY; Wielgosz G; Benzie RJ; Soltan HC; Jenner MR; Morland PA; Montgomery RJ; Allen LC
    CMAJ; 1987 Aug; 137(4):285-93. PubMed ID: 2440547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved reliability of a serum alpha-fetoprotein enzyme immunoassay compared with a radioimmunoassay.
    Peleg L; Slor H; Cordova T; Ayalon D; Legum C; Rudick A
    Isr J Med Sci; 1986; 22(3-4):215-9. PubMed ID: 2427476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated maternal serum alpha-fetoprotein and amniotic fluid alpha-fetoprotein after multifetal pregnancy reduction.
    Grau P; Robinson L; Tabsh K; Crandall BF
    Obstet Gynecol; 1990 Dec; 76(6):1042-5. PubMed ID: 1700349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-year results of routine alpha-fetoprotein testing on prenatal patients in a family practice.
    Weiss BD
    J Fam Pract; 1988 Mar; 26(3):273-80. PubMed ID: 2450166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal testing for maternal serum alpha-fetoprotein.
    Schwager EJ; Weiss BD
    Am Fam Physician; 1987 Apr; 35(4):169-74. PubMed ID: 2436465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Fetoprotein screening.
    Burton BK
    Adv Pediatr; 1986; 33():181-96. PubMed ID: 2432763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.